# Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule

> **NCT01058824** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** Lincomycin
- **DRUG:** Lincomycin

## Key facts

- **NCT ID:** NCT01058824
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01058824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01058824, "Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01058824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*